Viracta Therapeutics Inc (VIRX)
0.2003
0.00 (0.00%)
USD |
NASDAQ |
Nov 05, 16:00
0.2003
0.00 (0.00%)
After-Hours: 16:04
Viracta Therapeutics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 28, 2024 | 3.794 |
| June 27, 2024 | 4.033 |
| June 26, 2024 | 3.915 |
| June 25, 2024 | 3.984 |
| June 24, 2024 | 4.117 |
| June 21, 2024 | 4.363 |
| June 20, 2024 | 3.970 |
| June 18, 2024 | 4.264 |
| June 17, 2024 | 4.532 |
| June 14, 2024 | 4.702 |
| June 13, 2024 | 4.478 |
| June 12, 2024 | 4.536 |
| June 11, 2024 | 4.312 |
| June 10, 2024 | 4.068 |
| June 07, 2024 | 4.298 |
| June 06, 2024 | 4.430 |
| June 05, 2024 | 3.491 |
| June 04, 2024 | 4.047 |
| June 03, 2024 | 5.010 |
| May 31, 2024 | 4.885 |
| May 30, 2024 | 4.816 |
| May 29, 2024 | 4.693 |
| May 28, 2024 | 5.172 |
| May 24, 2024 | 5.129 |
| May 23, 2024 | 5.074 |
| Date | Value |
|---|---|
| May 22, 2024 | 5.310 |
| May 21, 2024 | 5.581 |
| May 20, 2024 | 5.631 |
| May 17, 2024 | 5.631 |
| May 16, 2024 | 5.653 |
| May 15, 2024 | 5.862 |
| May 14, 2024 | 5.610 |
| May 13, 2024 | 5.380 |
| May 10, 2024 | 5.303 |
| May 09, 2024 | 5.757 |
| May 08, 2024 | 5.729 |
| May 07, 2024 | 5.722 |
| May 06, 2024 | 5.583 |
| May 03, 2024 | 5.654 |
| May 02, 2024 | 5.862 |
| May 01, 2024 | 5.723 |
| April 30, 2024 | 5.719 |
| April 29, 2024 | 5.729 |
| April 26, 2024 | 5.780 |
| April 25, 2024 | 5.910 |
| April 24, 2024 | 5.836 |
| April 23, 2024 | 5.916 |
| April 22, 2024 | 6.141 |
| April 19, 2024 | 5.978 |
| April 18, 2024 | 6.343 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6905
Minimum
Dec 19 2023
8.164
Maximum
Apr 11 2024
2.136
Average
1.644
Median
Jan 16 2024
Price to Book Value Benchmarks
| Biomarin Pharmaceutical Inc | 2.326 |
| Arbutus Biopharma Corp | 6.097 |
| GlycoMimetics Inc | 1.253 |
| FibroGen Inc | -- |
| Cidara Therapeutics Inc | 0.7219 |
Price to Book Value Related Metrics
| Price | 0.2003 |
| Earnings Yield | -579.1% |
| Market Cap | 7.895M |